Fecal microbiome analysis as a diagnostic test for diverticulitis (Q35181039)

7 August 2017

Fecal microbiome analysis as a diagnostic test for diverticulitis (English)

1 reference

7 August 2017

0 references

0 references

1 reference

L Daniels

1

1 reference

7 August 2017

A E Budding

2

1 reference

7 August 2017

N de Korte

3

1 reference

7 August 2017

A Eck

4

1 reference

7 August 2017

J A Bogaards

5

1 reference

7 August 2017

H B Stockmann

6

1 reference

7 August 2017

E C Consten

7

1 reference

7 August 2017

P H Savelkoul

8

1 reference

7 August 2017

M A Boermeester

9

1 reference

7 August 2017

4 June 2014

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

7 August 2017

1 reference

7 August 2017

33

1 reference

7 August 2017

11

1 reference

7 August 2017

1927-1936

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-014-2162-3

7 August 2017

0 references

cites work

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Homeostasis and inflammation in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Immune adaptations that maintain homeostasis with the intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

The long-term stability of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Clinical practice. Diverticulitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Natural history of diverticular disease of the colon. A review of 521 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Robust estimation of microbial diversity in theory and in practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Tumor classification by partial least squares using microarray gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Towards the human intestinal microbiota phylogenetic core

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Use of antibiotics in uncomplicated diverticulitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Second Trimester Maternal Urine for the Diagnosis of Trisomy 21 and Prediction of Poor Pregnancy Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2162-3

Thoughts on the epidemiology of diverticular disease

21 January 2018

1 reference

12 December 2020

Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group

1 reference

12 December 2020

Probiotics in diverticular disease of the colon: an open label study.

1 reference

12 December 2020

Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach

1 reference

12 December 2020

Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome

1 reference

12 December 2020

Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension

1 reference

12 December 2020

A hypothesis: is diverticulitis a type of inflammatory bowel disease?

1 reference

12 December 2020

Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis

1 reference

12 December 2020

The natural history of diverticular disease of the colon: a role for antibiotics in preventing complications? A retrospective study

1 reference

12 December 2020

Survival of Human Dental Plaque Flora in Various Transport Media

1 reference

12 December 2020

Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria.

1 reference

12 December 2020

Same hospitalization resection for acute diverticulitis

1 reference

12 December 2020

Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial

1 reference

12 December 2020

A clinical decision rule to establish the diagnosis of acute diverticulitis at the emergency department

1 reference

12 December 2020

Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon

1 reference

12 December 2020

Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora

1 reference

12 December 2020

10.1007/S10096-014-2162-3

Identifiers

DOI

1 reference

7 August 2017

1 reference